cautionary < cell < cells

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000002 (2020)	L. Horvath [Allemagne] ; B. Hellmich [Allemagne]	[Treatment of giant cell arteritis and polymyalgia rheumatica].
000004 (2020)	Mike Becker [Suisse]	[Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
000007 (2020)	Danièle Allali ; Marc Blondon ; Pascale Roux-Lombard ; David Spoerl	[How to manage giant cell arteritis].
000017 (2020)	Franziska Düver [Allemagne] ; Benedikt Wei Brich [Allemagne] ; Matthias Eyrich [Allemagne] ; Matthias Wölfl [Allemagne] ; Paul G. Schlegel [Allemagne] ; Verena Wiegering [Allemagne]	Viral reactivations following hematopoietic stem cell transplantation in pediatric patients – A single center 11-year analysis
000031 (2020)	Jerome Razanamahery [France] ; Sebastien Humbert [France] ; Helder Gil [France] ; Kevin Bouiller [France] ; Nadine Magy-Bertrand [France]	Tropheryma Whipplei infection mimicking giant cell arteritis flare in a patient treated with interleukin-6 receptor blocker tocilizumab.
000033 (2020)	Isaure Vanmeerbeek [Belgique] ; Jenny Sprooten [Belgique] ; Dirk De Ruysscher [Pays-Bas] ; Sabine Tejpar [Belgique] ; Peter Vandenberghe [Belgique] ; Jitka Fucikova [République tchèque] ; Radek Spisek [République tchèque] ; Laurence Zitvogel [France] ; Guido Kroemer [France, République populaire de Chine, Suède] ; Lorenzo Galluzzi [États-Unis, France] ; Abhishek D. Garg [Belgique]	Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
000035 (2020)	Limin Li [République populaire de Chine] ; Jie Liu [République populaire de Chine] ; Mengyuan Xu [République populaire de Chine] ; Hongjuan Yu [République populaire de Chine] ; Chengfang Lv [République populaire de Chine] ; Fenglin Cao [République populaire de Chine] ; Zhenkun Wang [République populaire de Chine] ; Yueyue Fu [République populaire de Chine] ; Mingwen Zhang [République populaire de Chine] ; Hongbin Meng [République populaire de Chine] ; Xiaoqian Zhang [République populaire de Chine] ; Liqing Kang [République populaire de Chine] ; Zhuo Zhang [République populaire de Chine] ; Jinmei Li [République populaire de Chine] ; Jiawei Feng [République populaire de Chine] ; Xin Lian [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Jin Zhou [République populaire de Chine]	Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients
000038 (2020)	Maria C. Cid [Espagne] ; Roberto Ríos-Garcés [Espagne] ; Nekane Terrades-García [Espagne] ; Georgina Espígol-Frigolé [Espagne]	Treatment of giant-cell arteritis: from broad spectrum immunosuppressive agents to targeted therapies.
000046 (2020)	Gabriela Sanchez-Petitto [États-Unis] ; Noa G. Holtzman [États-Unis] ; Ali Bukhari [États-Unis] ; Matthew Brown [États-Unis] ; Megan K. Morales [États-Unis] ; Madhurima Koka [États-Unis] ; Jean A. Yared [États-Unis] ; Saurabh Dahiya [États-Unis] ; Aaron P. Rapoport [États-Unis] ; Nancy M. Hardy [États-Unis]	Toxoplasma-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation.
000068 (2020)	Changyow C. Kwan ; Preeti J. Thyparampil	Tocilizumab for Giant Cell Arteritis.
000076 (2020)	Philip George [Nouvelle-Zélande] ; Nathaniel Dasyam [Nouvelle-Zélande] ; Giulia Giunti [Nouvelle-Zélande] ; Brigitta Mester [Nouvelle-Zélande] ; Evelyn Bauer [Nouvelle-Zélande] ; Bethany Andrews [Nouvelle-Zélande] ; Travis Perera [Nouvelle-Zélande] ; Tess Ostapowicz [Nouvelle-Zélande] ; Chris Frampton [Nouvelle-Zélande] ; Peng Li [République populaire de Chine] ; David Ritchie [Australie] ; Catherine M. Bollard [États-Unis] ; Ian F. Hermans [Nouvelle-Zélande] ; Robert Weinkove [Nouvelle-Zélande]	Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE)
000087 (2020)	Wanhai Ke ; Li Zhang ; Yan Dai	The role of IL‐6 in immunotherapy of non‐small cell lung cancer (NSCLC) with immune‐related adverse events (irAEs)
000138 (2020)	Hao Zhang ; Yongxian Hu	Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib
000152 (2020)	Alfredo Sadun [États-Unis] ; Lynn Gordon	Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
000157 (2020)	Jingsheng Hua [République populaire de Chine] ; Weiqing Qian [République populaire de Chine] ; Xiaoxia Wu [République populaire de Chine] ; Lili Zhou [République populaire de Chine] ; Lei Yu [République populaire de Chine] ; Suning Chen [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Huiying Qiu [République populaire de Chine]	Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature
000167 (2020)	Peter A. Riedell ; Michael R. Bishop	Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
000201 (2020)	Naomi Serling-Boyd [États-Unis] ; John H. Stone	Recent advances in the diagnosis and management of giant cell arteritis.
000209 (2020)	Gonzalo De Luna [France] ; Anoosha Habibi [France] ; Jean François Deux [France] ; Martin Colard [France] ; Anne Laure Pham Hung D'Alexandry D'Orengiani [France] ; Frédéric Schlemmer [France] ; Nizar Joher [France] ; Christian Kassasseya [France] ; Jean Michel Pawlotsky [France] ; Clément Ourghanlian [France] ; Marc Michel [France] ; Armand Mekontso-Dessap [France] ; Pablo Bartolucci [France]	Rapid and Severe Covid-19 Pneumonia with Severe Acute Chest Syndrome in a Sickle Cell Patient Successfully Treated with Tocilizumab.
000219 (2020)	Ayako Matsumura [Japon] ; Takuya Miyazaki [Japon] ; Takayoshi Tachibana [Japon] ; Taiki Ando [Japon] ; Megumi Koyama [Japon] ; Satoshi Koyama [Japon] ; Yoshimi Ishii [Japon] ; Hiroyuki Takahashi [Japon] ; Yuki Nakajima [Japon] ; Ayumi Numata [Japon] ; Wataru Yamamoto [Japon] ; Kenji Motohashi [Japon] ; Maki Hagihara [Japon] ; Kenji Matsumoto [Japon] ; Shin Fujisawa [Japon] ; Hideaki Nakajima [Japon]	Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study
000221 (2020)	Yao-Chung Liu [Taïwan] ; Ting-An Lin [Taïwan] ; Hao-Yuan Wang [Taïwan] ; Po-Shen Ko [Taïwan] ; Chia-Jen Liu [Taïwan] ; Liang-Tsai Hsiao [Taïwan] ; Sheng-Hsuan Chien [Taïwan] ; Jyh-Pyng Gau [Taïwan]	Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report
000268 (2020)	Muhammad Khan [République populaire de Chine] ; Sumbal Arooj [Pakistan] ; Hua Wang [République populaire de Chine]	NK Cell-Based Immune Checkpoint Inhibition

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "cell" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "cell" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    cell
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021